BEGIN:VCALENDAR PRODID:-//Microsoft Corporation//Outlook 16.0 MIMEDIR//EN VERSION:2.0 METHOD:PUBLISH X-MS-OLK-FORCEINSPECTOROPEN:TRUE BEGIN:VTIMEZONE TZID:Central Standard Time BEGIN:STANDARD DTSTART:16011104T020000 RRULE:FREQ=YEARLY;BYDAY=1SU;BYMONTH=11 TZOFFSETFROM:-0500 TZOFFSETTO:-0600 END:STANDARD BEGIN:DAYLIGHT DTSTART:16010311T020000 RRULE:FREQ=YEARLY;BYDAY=2SU;BYMONTH=3 TZOFFSETFROM:-0600 TZOFFSETTO:-0500 END:DAYLIGHT END:VTIMEZONE BEGIN:VEVENT CLASS:PUBLIC CREATED:20211013T122927Z DESCRIPTION:Dr. Pamela Habib\, M.D.\, a Radiologist and Head of US Medical Affairs for Bayer Radiology\, will moderate a discussion with Dr. Leland S . Hu\, M.D.\, specific to the value of Dynamic Susceptibility Contrast (DS C)-MRI based Perfusion Weighted Imaging (PWI) in assisting radiologists in differentiating recurrent high-grade glioma vs. post-treatment effect. PW I using the DSC-MRI method is a very effective tool in evaluating gliomas\ , specifically glioblastomas\, which are the most common. Discussion will include the importance of technical acquisition considerations (e.g\,. pul se sequence parameters\, iv catheter placement\, etc). in achieving diagno stic quality. \n \nRSNA registration is necessary whether virtual or in-pe rson. Please check official RSNA 2021 program for updates.\n \n DTEND;TZID="Central Standard Time":20211130T110000 DTSTAMP:20211013T122927Z DTSTART;TZID="Central Standard Time":20211130T103000 LAST-MODIFIED:20211013T122927Z PRIORITY:5 SEQUENCE:0 SUMMARY;LANGUAGE=en-us:Bayer Virtual Theater Presentation | The Value of MR Perfusion in the Diagnosis and Follow up of Gliomas TRANSP:OPAQUE UID:040000008200E00074C5B7101A82E00800000000B020D2480CC0D701000000000000000 0100000009A02293AC08FE944A8AD9461512F427A X-ALT-DESC;FMTTYPE=text/html:< /head>

Dr. Pamela Habib\ , M.D.\, a Radiologist and Head of US Medical Affairs for Bayer Radiology\ , will moderate a discussion with Dr. Leland S. Hu\, M.D.\, specific to th e value of Dynamic Susceptibility Contrast (DSC)-MRI based Perfusion Weigh ted Imaging (PWI) in assisting radiologists in differentiating recurrent h igh-grade glioma vs. post-treatment effect. PWI using the DSC-MRI method i s a very effective tool in evaluating gliomas\, specifically glioblastomas \, which are the most common. Discussion will include the importance of te chnical acquisition considerations (e.g\,. pulse sequence parameters\, iv catheter placement\, etc). in achieving diagnostic quality.

 \;

RSNA registration is necessary whether virtual or in-person. Please check official RSNA 2021 program for upd ates.

 \;

X-MICROSOFT-CDO-BUSYSTATUS:BUSY X-MICROSOFT-CDO-IMPORTANCE:1 X-MICROSOFT-DISALLOW-COUNTER:FALSE X-MS-OLK-CONFTYPE:0 BEGIN:VALARM TRIGGER:-PT15M ACTION:DISPLAY DESCRIPTION:Reminder END:VALARM END:VEVENT END:VCALENDAR